These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 21249320)
1. Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines. Tamura T; Shomori K; Nakabayashi M; Fujii N; Ryoke K; Ito H Oncol Rep; 2011 Apr; 25(4):1139-43. PubMed ID: 21249320 [TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers. Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752 [TBL] [Abstract][Full Text] [Related]
3. The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis. Sewing L; Steinberg F; Schmidt H; Göke R Apoptosis; 2008 Jun; 13(6):782-9. PubMed ID: 18437576 [TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status. Ory B; Blanchard F; Battaglia S; Gouin F; Rédini F; Heymann D Mol Pharmacol; 2007 Jan; 71(1):333-43. PubMed ID: 17050806 [TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines. Koshimune R; Aoe M; Toyooka S; Hara F; Ouchida M; Tokumo M; Sano Y; Date H; Shimizu N BMC Cancer; 2007 Jan; 7():8. PubMed ID: 17222343 [TBL] [Abstract][Full Text] [Related]
6. Combined effects of bisphosphonate and radiation on osteosarcoma cells. Ryu K; Murata H; Koto K; Horie N; Matsui T; Nishigaki Y; Sakabe T; Takeshita H; Itoi M; Kimura S; Ashihara E; Maekawa T; Fushiki S; Kubo T Anticancer Res; 2010 Jul; 30(7):2713-20. PubMed ID: 20683003 [TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. Goffinet M; Thoulouzan M; Pradines A; Lajoie-Mazenc I; Weinbaum C; Faye JC; Séronie-Vivien S BMC Cancer; 2006 Mar; 6():60. PubMed ID: 16539721 [TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners. Okamoto S; Kawamura K; Li Q; Yamanaka M; Yang S; Fukamachi T; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Kobayashi H; Tagawa M J Thorac Oncol; 2012 May; 7(5):873-82. PubMed ID: 22481236 [TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1. Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912 [TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect. Corso A; Ferretti E; Lunghi M; Zappasodi P; Mangiacavalli S; De Amici M; Rusconi C; Varettoni M; Lazzarino M Cancer; 2005 Jul; 104(1):118-25. PubMed ID: 15895374 [TBL] [Abstract][Full Text] [Related]
11. 2'-Hydroxycinnamaldehyde shows antitumor activity against oral cancer in vitro and in vivo in a rat tumor model. Kim SA; Sung YK; Kwon BM; Yoon JH; Lee H; Ahn SG; Hong SH Anticancer Res; 2010 Feb; 30(2):489-94. PubMed ID: 20332459 [TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes. Ohnuki H; Izumi K; Terada M; Saito T; Kato H; Suzuki A; Kawano Y; Nozawa-Inoue K; Takagi R; Maeda T Arch Oral Biol; 2012 Jul; 57(7):906-17. PubMed ID: 22172403 [TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents. Koto K; Murata H; Kimura S; Horie N; Matsui T; Nishigaki Y; Ryu K; Sakabe T; Itoi M; Ashihara E; Maekawa T; Fushiki S; Kubo T Oncol Rep; 2010 Jul; 24(1):233-9. PubMed ID: 20514467 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines. Matsumoto S; Kimura S; Segawa H; Kuroda J; Yuasa T; Sato K; Nogawa M; Tanaka F; Maekawa T; Wada H Lung Cancer; 2005 Jan; 47(1):31-9. PubMed ID: 15603852 [TBL] [Abstract][Full Text] [Related]
15. The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro. Mitrofan LM; Pelkonen J; Mönkkönen J Bone; 2009 Dec; 45(6):1153-60. PubMed ID: 19699819 [TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of zoledronic acid against human osteosarcoma cells. Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111 [TBL] [Abstract][Full Text] [Related]
17. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Lin CC; Yang JS; Chen JT; Fan S; Yu FS; Yang JL; Lu CC; Kao MC; Huang AC; Lu HF; Chung JG Anticancer Res; 2007; 27(5A):3371-8. PubMed ID: 17970083 [TBL] [Abstract][Full Text] [Related]
19. The p38 MAPK pathway is critical for 5,5'-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells. Choi KH; Kim HK; Kim JH; Choi ES; Shin JA; Lee SO; Chintharlapalli S; Safe S; Abdelrahim M; Kong G; Choi HS; Jung JY; Cho HT; Cho NP; Cho SD Eur J Cancer Prev; 2010 Mar; 19(2):153-9. PubMed ID: 19949342 [TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83. Ge XY; Yang LQ; Jiang Y; Yang WW; Fu J; Li SL PLoS One; 2014; 9(6):e101207. PubMed ID: 24963720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]